Vaccines Shakeup Continues In China: NT Pharma Backs Away From GSK

NT Pharma is positioning its decision as an effort to concentrate resources on becoming an end-to-end service provider, but the impact of the new 2010 Chinese Pharmacopoeia on vaccines manufactured by multinational companies may also have been a consideration.